Xilio Therapeutics, Inc. Quarterly Return On Assets in % from Q2 2022 to Q3 2024

Taxonomy & unit
ratio: %
Description
Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Summary
Xilio Therapeutics, Inc. quarterly/annual Return On Assets history and growth rate from Q2 2022 to Q3 2024.
  • Xilio Therapeutics, Inc. Return On Assets for the quarter ending September 30, 2024 was -81.5 %, a 5.65% decline year-over-year.
  • Xilio Therapeutics, Inc. annual Return On Assets for 2023 was -89.2 %, a 69.6% decline from 2022.
Return On Assets, Quarterly (%)
Return On Assets, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q3 2024 -81.5 -4.36 -5.65% Jul 1, 2024 Sep 30, 2024
Q2 2024 -84.2 -16.9 -25.1% Apr 1, 2024 Jun 30, 2024
Q1 2024 -90.5 -29.4 -48.1% Jan 1, 2024 Mar 31, 2024
Q4 2023 -89.2 -36.6 -69.6% Oct 1, 2023 Dec 31, 2023
Q3 2023 -77.2 -31.6 -69.4% Jul 1, 2023 Sep 30, 2023
Q2 2023 -67.4 -21.4 -46.6% Apr 1, 2023 Jun 30, 2023
Q1 2023 -61.1 Jan 1, 2023 Mar 31, 2023
Q4 2022 -52.6 Oct 1, 2022 Dec 31, 2022
Q3 2022 -45.6 Jul 1, 2022 Sep 30, 2022
Q2 2022 -45.9 Apr 1, 2022 Jun 30, 2022
* An asterisk sign (*) next to the value indicates that the value is likely invalid.